More about

Incurable Cancer

News
April 17, 2020
4 min read
Save

Quality of life assessments in oncology trials often don’t — but should — go ‘well beyond treatment’

Most oncology clinical trials that assess quality of life do so only during or shortly after the treatment or intervention rather than continuing after disease progression or until death, according to results of a cross-sectional analysis published in JAMA Network Open.